Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise
Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise ( Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA )
8 Dec 2019
Evaluating emerging mutations in patients with acute myeloid leukaemia who relap...
Dr Catherine Smith - University of California San Francisco, San Francisco, USA
Evaluating emerging mutations in patients with acute myeloid leukaemia who relapsed while receiving gilteritinib therapy in the ADMIRAL trial ( Dr Catherine Smith - University of California San Francisco, San Francisco, USA )
8 Dec 2019
Simplifying molecular subtypes of metastatic gastric cancer
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
Simplifying molecular subtypes of metastatic gastric cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )
8 Oct 2019
Association between tTMB and clinical outcomes with pembrolizumab alone in PD-L1...
Prof Roy Herbst - Yale Cancer Center, New Haven, USA
Association between tTMB and clinical outcomes with pembrolizumab alone in PD-L1-positive advanced NSCLC in KEYNOTE-010 and -042 ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )
4 Oct 2019
Targeted therapies in prostate cancer: Recent advances presented at ESMO 2019
Dr Eleni Efstathiou, Prof Noel Clarke, Dr Elena Castro, Prof Matthew Smith
Targeted therapies in prostate cancer: Recent advances presented at ESMO 2019 ( Dr Eleni Efstathiou, Prof Noel Clarke, Dr Elena Castro, Prof Matthew Smith )
30 Sep 2019
VELIA/GOG-3005 trial: Veliparib for high-grade serous carcinoma of ovarian, fall...
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
VELIA/GOG-3005 trial: Veliparib for high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
28 Sep 2019
Appraising an NTRK testing algorithm: When, what, how
Professor Jean-Yves Blay and Professor Frédérique Penault-Llorca
Appraising an NTRK testing algorithm: When, what, how ( Professor Jean-Yves Blay and Professor Frédérique Penault-Llorca )
16 Sep 2019
Oncogenomics: From a surgical perspective
Dr Gonzalo Ziegler - Clínica Ziegler, Lima, Perú
Oncogenomics: From a surgical perspective ( Dr Gonzalo Ziegler - Clínica Ziegler, Lima, Perú )
7 Aug 2019
Using ctDNA to predict recurrence and response in colorectal cancer
Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA
Using ctDNA to predict recurrence and response in colorectal cancer ( Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA )
15 Jul 2019
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in pa...
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019
Oncobox, RNA sequencing and molecular pathway analysis-base system for prescript...
Dr Anton Buzdin - Sechenov Moscow First Medical University, Moscow, Russia
Oncobox, RNA sequencing and molecular pathway analysis-base system for prescription of target drugs to advanced cancer patients ( Dr Anton Buzdin - Sechenov Moscow First Medical University, Moscow, Russia )
10 Jul 2019
Decision support for precision oncology: Evolving from monotherapy to genomicall...
Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA
Decision support for precision oncology: Evolving from monotherapy to genomically informed combinations ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )
10 Jul 2019